1.
Lee H, Duggan P, Neri EP, Tay J, Zepeda V. Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance. MJHID [Internet]. 1Jan.2019 [cited 21Mar.2019];11(1):e2019007. Available from: http://mjhid.org/index.php/mjhid/article/view/2019.007